Patent · US Active

Compounds and methods for inhibition of AP endonuclease-1/redox factor-1 (HAPE1) activity

US9624235B2 · kind B2 · utility

2Cited by

1References

5Claims

0Family size

Assignee

University of Pittsburgh—Of the Commonwealth System of Higher Education · US

Inventors

Barry I. Gold · Pittsburgh, US
Xiangqun Xie · Pittsburgh, US
Ajay Srinivasan · Mumbai, IN
Lirong Wang · Beijing, CN

Key dates

Filing date	Jan 29, 2013
Grant date	Apr 18, 2017
Priority date	—
Expiry date	Jan 29, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y402/99018
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for treating a neoplasm in a subject, comprising co-administering to the subject a therapeutically effective amount of an anticancer agent and a substituted 6,7-methylenedioxy-4-amino-quinoline, or a pharmaceutically acceptable salt or ester thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.